Nkarta NKTX
NASDAQ NKTX
$1.48 +0.13 (+9.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Nkarta (NKTX) Asset Utilization Ratio (2020)

Updated

Nkarta's (NKTX) Asset Utilization Ratio came in at 0.00 for Q4 2020.

Analysis

Nkarta (NKTX) Asset Utilization Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Nkarta 96.80 Mn -1.37 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 0.00
API Access

Nkarta Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NKTX&period=max&api_key=YOUR_API_KEY